Jazz Pharmaceuticals Plc (JAZZ)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.69% 1,126.11	1,045.71	897.84	1,088.17	1,054.97
Operating Expenses	38.31% 1,068.60	1,732.10	953.73	897.40	794.76
Benefits Costs and Expenses	37.29% 1,117.07	1,781.27	1,007.65	954.95	854.16
Costs And Expenses	38.31% 1,068.60	1,732.10	953.73	897.40	794.76
Operating Income/Loss	108.38% 57.51	-686.39	-55.89	190.77	260.21
Income/Loss Before Equity Method Investments	101.23% 9.035	-735.55	-109.81	133.22	200.81
Income/Loss From Equity Method Investments	45.35% -0.047	-0.086	-0.542	-0.016	-0.285
Income/Loss From Continuing Operations Before Tax	101.23% 9.035	-735.55	-109.81	133.22	200.81
Income Tax Expense/Benefit, Deferred	308.63% -271.41	-66.42	-43.83	-2.355	-64.40
Income Tax Expense/Benefit	1,312% -242.42	-17.17	-17.81	-57.91	-14.53
Income/Loss From Continuing Operations After Tax	135.00% 251.46	-718.47	-92.54	191.13	215.34
Net Income/Loss	134.99% 251.41	-718.47	-92.54	191.12	215.06
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.81% 60.70	61.19	60.98	-0.437	61.41
Diluted Average Shares	0.67% 61.61	61.19	60.98	-1.504	63.17
Basic Earnings Per Share	135.26% 4.14	-11.74	-1.52	3.13	3.50
Diluted Earnings Per Share	134.75% 4.08	-11.74	-1.52	3.02	3.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%